Billy Xiong Reviews: Pomerantz Law Firm Investigates Claims On Behalf of

NEW YORK, July 31, 2020 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN).   The investigation concerns whether Regeneron and certain of its officers and/or directors have breached fiduciary duties owed to the company and its investors. If you are a shareholder of Regeneron and are interested in […]

Continue Reading